Donna L. Dehn

1.3k citations

17 papers · 1.1k indexed · h-index 13

Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents 9
Molecular Biology top 10%
- Genomics, phytochemicals, and oxidative stress 6
- Cancer therapeutics and mechanisms 4
- Coenzyme Q10 studies and effects 2
- Protein Structure and Dynamics 1
Organic Chemistry top 10%
Physiology top 10%
Immunology
Epidemiology
- Cervical Cancer and HPV Research 3
Oncology
- Cancer Cells and Metastasis 2
Urology
- Hair Growth and Disorders 1

Co-authors: David Ross David Siegel Preecha Boonchoong Jin Yi Han Daniel L. Gustafson Lawrence J. Berliner Kenneth R. Shroyer Kathleen C. Torkko
Cited by: Toxicology Molecular Biology Organic Chemistry
Journals: Journal of Biological Chemistry (1 paper)Cancer (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States United Kingdom Japan

In The Last Decade

Donna L. Dehn

17 papers receiving 1.1k citations

Peers

Countries citing papers authored by Donna L. Dehn

Since Specialization

Citations

This map shows the geographic impact of Donna L. Dehn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna L. Dehn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna L. Dehn more than expected).

Fields of papers citing papers by Donna L. Dehn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna L. Dehn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna L. Dehn. The network helps show where Donna L. Dehn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Donna L. Dehn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donna L. Dehn Line = papers co-authored together Donna L. Dehn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Redox Modulation of NQO1 The FASEB Journal ·David J. Siegel,Donna L. Dehn,Kevin Quinn,Donald S. Backos,Andrea Di Francesco,Michel Bernier,Nichole Reisdorph,Rafael de Cabo,David Ross	2018	1
2	Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90 Nature Chemistry ·Russell R. A. Kitson,Chuan‐Hsin Chang,Rui Xiong,Huw E. L. Williams,Adrienne L. Davis,William Lewis,Donna L. Dehn,David Siegel,S. Mark Roe,Chrisostomos Prodromou,David Ross,Christopher J. Moody	2013	64
3	p16^INK4a is superior to high‐risk human papillomavirus testing in cervical cytology for the prediction of underlying high‐grade dysplasia Cancer Cytopathology ·Panduka Samarawardana,Donna L. Dehn,Meenakshi Singh,Douglas W. Franquemont,Chesney Thompson,Loretta Gaido,Kathleen C. Torkko,Petra Homer,Stephanie Burke,Matthew A. Titmus,Vipul Nayi,Kenneth R. Shroyer	2010	38
4	NAD(P)H:quinone Oxidoreductase 1-Compromised Human Bone Marrow Endothelial Cells Exhibit Decreased Adhesion Molecule Expression and CD34+ Hematopoietic Cell Adhesion Journal of Pharmacology and Experimental Therapeutics ·Hongfei Zhou,Donna L. Dehn,Jadwiga K. Kepa,David Siegel,Devon Scott,Wei Tan,David Ross	2010	12
5	Screening for Molecular Markers of Cervical Papillomavirus Infection: Overview of Methods and Their Clinical Implications Methods in molecular biology ·Donna L. Dehn,A. Taylor,Timothy J. Fischer,Douglas P. Malinowski,Kenneth R. Shroyer	2009	2
6	NQO1 Expression in Pancreatic Cancer and Its Potential Use as a Biomarker Applied immunohistochemistry & molecular morphology ·Nida S. Awadallah,Donna L. Dehn,Raj J. Shah,S. Russell Nash,Yang K. Chen,David Ross,Joel S. Bentz,Kenneth R. Shroyer	2008	67
7	B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration Gynecologic Oncology ·Takashi Miyatake,Barbara Tringler,Wenhui Liu,Shu‐Hui Liu,Jackie Papkoff,Takayuki Enomoto,Kathleen C. Torkko,Donna L. Dehn,Ashanta Swisher,Kenneth R. Shroyer	2007	95
8	Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma Cancer ·Donna L. Dehn,Kathleen C. Torkko,Kenneth R. Shroyer	2007	84
9	5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo Molecular Cancer Therapeutics ·Donna L. Dehn,David Siegel,Khan Shoeb Zafar,Philip Reigan,Elizabeth Swann,Christopher J. Moody,David Ross	2006	34
10	RH1 Induces Cellular Damage in an NAD(P)H:Quinone Oxidoreductase 1-Dependent Manner: Relationship between DNA Cross-linking, Cell Cycle Perturbations, and Apoptosis Journal of Pharmacology and Experimental Therapeutics ·Donna L. Dehn,Salmaan H. Inayat‐Hussain,David Ross	2005	26
11	NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide Scavenger Molecular Pharmacology ·David Siegel,Daniel L. Gustafson,Donna L. Dehn,Jin Yi Han,Preecha Boonchoong,Lawrence J. Berliner,David Ross	2004	389
12	Development of a New Isogenic Cell-Xenograft System for Evaluation of NAD(P)H:Quinone Oxidoreductase-Directed Antitumor Quinones Clinical Cancer Research ·Donna L. Dehn,Shannon L. Winski,David Ross	2004	30
13	Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free Systems Journal of Biological Chemistry ·Adil Anwar,Donna L. Dehn,David Siegel,Jadwiga K. Kepa,Luo Jia Tang,Jennifer A. Pietenpol,David Ross	2003	119
14	Biochemical, Cytotoxic, and Genotoxic Effects of ES936, a Mechanism-Based Inhibitor of NAD(P)H:quinone Oxidoreductase 1, in Cellular Systems Molecular Pharmacology ·Donna L. Dehn,David Siegel,Elizabeth Swann,Christopher J. Moody,David Ross	2003	45
15	Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones 1 2 1In accordance with the policy of the University of Colorado Health Sciences Center, D.R., R.H.J.H., and J.B. declare a patent interest in RH1. 2Abbreviations: MMC, mitomycin C; NQO1, NAD(P)H:quinone oxidoreductase 1 or DT-diaphorase; MeDZQ, 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone; DCPIP, 2,6-dichlorophenol-indophenol; MTT, thiazolyl blue; P450R, NADPH:cytochrome P450 reductase; b5R, NADH:cytochrome b5 reductase; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; FBS, fetal bovine serum; and MEM, Eagle’s minimum essential medium. Biochemical Pharmacology ·Shannon L. Winski,Elizabeth Swann,Robert H. J. Hargreaves,Donna L. Dehn,John Butler,Christopher J. Moody,David Ross	2001	74
16	Nicotine and Cotinine Adducts of a Melanin Intermediate Demonstrated by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Chemical Research in Toxicology ·Donna L. Dehn,David J. Claffey,Mark W. Duncan,James A. Ruth	2001	25
17	Deposition and retention of radiolabeled serum constituents in hair after systemic administration. PubMed ·P. R. Stout,Donna L. Dehn,James A. Ruth	1998	7

About Donna L. Dehn

Donna L. Dehn is a scholar working on Toxicology, Physiology and Microbiology, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (9 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Cancer therapeutics and mechanisms (4 papers), Cervical Cancer and HPV Research (3 papers), Coenzyme Q10 studies and effects (2 papers), Cancer Cells and Metastasis (2 papers), Hair Growth and Disorders (1 paper) and Protein Structure and Dynamics (1 paper). The work is most often cited by research in Toxicology (332 citations), Molecular Biology (714 citations) and Organic Chemistry (207 citations). Donna L. Dehn has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include David Ross, David Siegel, Preecha Boonchoong, Jin Yi Han, Daniel L. Gustafson, Lawrence J. Berliner, Kenneth R. Shroyer, Kathleen C. Torkko, Christopher J. Moody and Elizabeth Swann. Their work appears in journals such as Journal of Biological Chemistry, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact